Diencephalic syndrome

Diencephalic syndrome (also known as Russell syndrome or diencephalic syndrome of infancy) is a rare condition most commonly caused by a low-grade tumor (typically a pilocytic astrocytoma) located in the hypothalamic-optic chiasm region of the brain (diencephalon). The ICD-10 code C72.8 reflects its association with malignant or uncertain-behavior neoplasms of the central nervous system. The syndrome predominantly affects infants and young children, usually presenting in the first two years of life. The hallmark feature is severe emaciation (cachexia) with loss of subcutaneous fat despite apparently normal or even increased caloric intake. Paradoxically, affected children may appear alert, euphoric, and hyperactive despite their profoundly malnourished appearance. Key clinical features include failure to thrive with progressive weight loss, an emaciated appearance contrasting with relatively preserved linear growth, nystagmus (involuntary eye movements), pallor without true anemia, and sometimes macrocephaly due to hydrocephalus. Visual disturbances may occur depending on the tumor's involvement of the optic pathways. Endocrine abnormalities related to hypothalamic dysfunction, including growth hormone dysregulation, may also be present. Some patients develop vomiting, irritability, or signs of increased intracranial pressure as the tumor grows. Treatment is directed at the underlying tumor and may include surgical resection, chemotherapy, and in some cases radiation therapy, though the latter is generally avoided in very young children due to neurotoxic effects. Chemotherapy regimens (such as carboplatin and vincristine combinations) are often the first-line treatment for young children with hypothalamic/optic pathway gliomas. Nutritional support is an important component of management. Prognosis varies depending on the tumor type, extent, and response to treatment. While pilocytic astrocytomas are generally low-grade, their location in the hypothalamic region makes complete surgical removal challenging, and long-term outcomes can be complicated by endocrine deficiencies, visual impairment, and neurodevelopmental issues.

Common questions about Diencephalic syndrome